Navigation Links
Lucas Bagnell Varga LLC Secures $17.4 Million Award For Former Applied Biosystems Executives
Date:12/6/2012

SOUTHPORT, Conn., Dec. 6, 2012 /PRNewswire/ --  A three-member panel of the American Abritration Association today awarded former executives of Applied Biosystems, Inc., f/k/a Perkin Elmer Corporation, $17.4 million in unpaid change in control benefits from Life Technologies Corporation, one of the world's largest biotechnology companies. (NASDAQ:   LIFE).  The case was presented to a former federal judge, former state judge and a senior member of the Connecticut Bar over a period of two years.  According to the claim of the executives, the incentive compensation became due from Life Technologies Corporation when it assumed the obligations of the executives' employment agreements after acquiring Applied Biosystems, Inc. in November 2008.  Life Technologies argued the executives were misreading their agreements and were not entitled to continued stock-based benefit awards.   

In finding for the executives, the arbitration Panel held the agreements were breached as "the Company made no effort to provide [the claimed benefits], and the Claimants are entitled to them."  "We are very pleased with the outcome, and are happy our clients will finally receive these sums which they earned and are long overdue," said Scott Lucas, lead trial counsel for the executives.  "Consultants from Citrin Cooperman were instrumental in helping us present our clients' complex damages claim to the Panel," added Jeff Bagnell, who handled the damages aspect of the case at trial. 

The executives were represented by Lucas Bagnell Varga LLC in Southport, Connecticut.  Life Technologies was represented by DLA Piper.

Media Contact:
Jeff Bagnell
1-203-227-8400
jbagnell@lbv-law.com


'/>"/>
SOURCE Lucas Bagnell Varga LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies
2. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
3. Roka Bioscience Secures $47.5 Million in Series D Financing
4. Generex Secures Commitments for $3.6M Capital Raise
5. PharmAthene Secures $7.5 Million Credit Facility From GE Capital, Healthcare Financial Services
6. Insmed Secures $20 Million Loan Agreement With Hercules Technology Growth Capital
7. Bacterin Secures $25 Million Financing with OrbiMed
8. OncoSec Secures License for Electroporation Intellectual Property from University of South Florida
9. Aviir Diagnostic Laboratories Secures $8 Million In Funding From Silicon Valley Bank
10. Syngenta Secures EU Approval For Next Generation Fungicide
11. Amarantus BioSciences Secures $1.1 Million in Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) today ... based Phase 1 trial with severe kidney ... reducing inflamed protein biomarkers in patients with severe kidney ... this is the first time in medical history that ... between epigenetic regulation and its potential for positive disease ...
(Date:1/23/2017)... ... January 23, 2017 , ... CallTower is proud to announce ... of the Year Award winner for 2017. , For three consecutive years, CallTower ... In 2016, CallTower was awarded with the hosted VoIP Excellence award and in 2015, ...
(Date:1/21/2017)... -- Bioptix, Inc. (Nasdaq: BIOP ... 14, 2017 the Board of Directors of the Company ... certain employees associated with the September 2016 acquisition of ... on January 16, 2017 and terminations are expected to ... severance benefits in certain circumstances of up to one ...
(Date:1/20/2017)... , Jan. 20, 2017 Ginkgo Bioworks, ... Gen9, a pioneer in the synthesis and assembly ... expertise in assembling pathway-length synthetic DNA into Ginkgo,s ... capacity in the construction of new organism designs ... "Gen9 was founded to significantly increase ...
Breaking Biology Technology:
(Date:12/16/2016)... , Dec. 16, 2016   IdentyTechSolutions ... Identity management products and solutions and a cutting-edge ... today that it is offering seamless, integrated solutions ... security entrance products. The solutions provide IdentyTech,s customers ... secure their facilities from crime and theft. ...
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, ... held genomics technology company, announced today that on December ... Qualifications Department of The Nasdaq Stock Market LLC which ... bid price of WaferGen,s common stock had been at ... WaferGen has regained compliance with Listing Rule 5550(a)(2) of ...
(Date:12/15/2016)... , Dec. 14, 2016 "Increase in mobile ... market" The mobile biometrics market is expected to grow ... billion by 2022, at a CAGR of 29.3% between ... such as the growing demand for smart devices, government ... "Software component is expected to grow at ...
Breaking Biology News(10 mins):